XML 54 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2016
Segment Reporting Information [Line Items]      
Net sales $ 187,987 $ 187,120  
Depreciation and amortization 6,318 5,429  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 17,572 23,492  
Interest expense, net 3,907 3,819  
Depreciation and amortization 6,318 5,429  
Acquisition-related accrued compensation 420 420  
Foreign currency (gains) losses, net (334) 5,453  
Identifiable assets 598,084   $ 607,835
Operating Segments      
Segment Reporting Information [Line Items]      
Depreciation and amortization 5,658 4,678  
Adjusted EBITDA - Total segments 37,349 34,722  
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 17,572 23,492  
Interest expense, net 3,907 3,819  
Depreciation and amortization 5,658 4,678  
Acquisition-related accrued compensation 420 420  
Acquisition-related transaction costs 1,274  
Adjusted EBITDA - Total segments 37,349 34,722  
Foreign currency (gains) losses, net (334) 5,453  
Identifiable assets 516,187   524,247
Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 124,501 120,134  
Depreciation and amortization 4,898 3,876  
Adjusted EBITDA - Total segments 32,619 31,476  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 4,898 3,876  
Adjusted EBITDA - Total segments 32,619 31,476  
Identifiable assets 435,512   444,751
Operating Segments | Mineral Nutrition      
Segment Reporting Information [Line Items]      
Net sales 51,592 54,469  
Depreciation and amortization 542 608  
Adjusted EBITDA - Total segments 3,988 3,160  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 542 608  
Adjusted EBITDA - Total segments 3,988 3,160  
Identifiable assets 59,687   57,939
Operating Segments | Performance Products      
Segment Reporting Information [Line Items]      
Net sales 11,894 12,517  
Depreciation and amortization 218 194  
Adjusted EBITDA - Total segments 742 86  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 218 194  
Adjusted EBITDA - Total segments 742 86  
Identifiable assets 21,557   20,988
Operating Segments | MFAs and other | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 83,419 85,521  
Operating Segments | Nutritional specialties | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 26,304 22,370  
Operating Segments | Vaccines | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 14,778 12,243  
Corporate      
Segment Reporting Information [Line Items]      
Depreciation and amortization 660 751  
Adjusted EBITDA - Total segments 7,524 7,015  
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 660 751  
Adjusted EBITDA - Total segments 7,524 $ 7,015  
Identifiable assets $ 81,897   $ 83,588